CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Lexaria Bioscience Corp.  (LXRP)
Other Ticker:  
 
 
Price: $1.4700 $-0.12 -7.547%
Day's High: $ 1.645 Week Perf: 16.67 %
Day's Low: $ 1.43 30 Day Perf: 37.38 %
Volume (M): 303 52 Wk High: $ 2.43
Volume (M$): $ 445 52 Wk Avg: $ 1.55
Open: 1.60 52 Wk Low: 0.78
You need to upgrade your Flash Player


 Market Capitalization (Millions $) 112
 Shares Outstanding (Millions) 76
 Employees 4
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -7
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Lexaria Bioscience Corp.
Our company’s business plan is currently focused on the development of strategic partnerships with licensees for our patented technology in exchange for up front and/or staged licensing fees over time. Secondarily and more generally, we continue to investigate national and international opportunities for development and distribution of the Company’s enhanced functional food and supplement product offerings; to investigate expansions and additions to our intellectual property portfolio; and, to search for additional opportunities in alternative health sectors. This includes the acquisition or development of intellectual property if and when we believe it advisable to do so. We announced issuance of our first patent by the U.S. Patent and Trademark Office (USPTO) on October 26, 2016 and have received a Notice of Acceptance from the Australian Patent Office with related patent issuance date June 15 2017 No. 2015274698. We announced on November 2, 2017 a new Notice of Allowance from the USPTO that included the delivery of additional molecules such as psychoactive cannabinoids, vitamins, non-steroidal anti-inflammatories, and nicotine all utilizing our DehydraTECHTM delivery technology. We are seeking additional patent protection for what we believe to be a unique process for the nutritional delivery of certain molecules such as cannabinoids, Nicotine, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Vitamins. To achieve sustainable and profitable growth, our company intends to control the timing and costs of our projects wherever possible.


 

Lexaria Bioscience's Segments
 
 
 
Company Estimates
 
 
  Revenue Outlook
   Lexaria Bioscience does not issue revenue guidance.

  Earnings Outlook
   Lexaria Bioscience Corp. does not provide earnings estimates.  

 

Eaco Corp

Growth, Growth, Growth

Eaco Corp showed respectable growth in the first quarter, where earnings jumped by 62.5 % year on year to $0.39 per share and Sales increased by 20.43 % to $50.79 millions.

Sono Tek Corp

Break-even, Single Digit Topline Growth

In the third quarter Sono Tek Corp reached break-even of $0.00 per share compare to $0.01 a year ago and from $0.00 per share from the previous quarter.

Sales grew by 5.8 % to $3.16 millions from $2.98 millions in the same quarter a year ago and sequentially Sales advanced by 11.98 % from $2.82 millions.

Educational Development Corp

Strong Double Digit EPS Growth, Sales very Strong

In the third quarter Educational Development Corp profits soared by 36 % of $0.34 per share compare to $0.25 a year ago and eps soared by 88.89 % from $0.18 per share from the previous quarter.

Sales grew strongly by 67.41 % to $40.48 millions from $24.18 millions in the same quarter a year ago and sequentially Sales surged by 64.02 % from $24.68 millions.

Digital Brand Media & Marketing Group, Inc.

Break-even, Sales Weak

In the first quarter Digital Brand Media & Marketing Group, Inc reached break-even of $0.00 per share compare to $0.00 a year ago and from $0.00 per share from the previous quarter.

Sales declined in double digits by -16.12 % to $0.12 millions from $0.15 millions in the same quarter a year ago and sequentially Sales surged by 68.38 % from $0.07 millions.

Cls Holdings Usa, Inc.

Cls Holdings Usa, Inc announced second quarter operating loss of $-2.046793 millions

In the second quarter Cls Holdings Usa, Inc decreased loss of $-0.03 per share compare to $-0.07 a year ago and improved from $-0.23 per share from the previous quarter.

Sales remained unchanged to $1.98 millions from $0.00 millions in the same quarter a year ago and sequentially Sales surged by 67.63 % from $1.18 millions.






You need to upgrade your Flash Player

   
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   



     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RGPT's Profile

Stock Price

RGPT's Financials

Business Description

Fundamentals

Charts & Quotes

RGPT's News

Suppliers

RGPT's Competitors

Customers & Markets

Economic Indicators

RGPT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071